世界卫生组织（WHO）：2023年全球抗菌药物开发报告（英文版）

This report presents an analysis of antibacterial agents in preclinical (fourth annual review) and clinical (sixth annual review) development. The analysis covers traditional (direct-acting small molecules) and non-traditional antibacterial agents in development worldwide. It evaluates to what extent the present pipeline addresses infections caused by priority pathogens according to the updated 2024 WHO bacterial